covid.joinzoe.com/post/oestrogen-covid
LONDON, UK - The COVID Symptom Study today announces it will be working together with NHS England to facilitate key research into the potential protective effects of hormonal therapies, like HRT or the pill, and COVID-19. View our webinar on oestrogen and COVID-19 here.
More than 3 million people in the UK have provided data via the COVID Symptom Study app, launched by researchers at King’s College London and health technology company ZOE. This is the largest group of participants contributing to COVID-19 research in the world. Unlike contact tracing apps, The COVID Symptom Study app focuses on gathering health data to advance research into understanding the disease and providing short and long-term clinical solutions for the Nation’s recovery.
The COVID Symptom Study app has been updated to include specific questions about periods, hormone medications and menopause with the aim to better understand how hormones such as oestrogen might influence COVID-19 outcomes. The data will shed more light on the underlying reasons why there are sex-based differences in the response to coronavirus infection and the role of hormones in the disease as demonstrated in COVID Symptom Study data on hospitalisation.
Dr Louise Newson, advisor to NHS England, GP and menopause specialist commented:
“The COVID Symptom Study volunteers are an amazing resource that can answer a powerful question about the role of hormones in Covid-19 in a matter of days which can help the NHS save lives.”
Tim Spector, Professor of Genetic Epidemiology at King’s College London:
“We are really pleased to be working with NHS England and our millions of citizen scientists to help progress our understanding of COVID-19. It’s fantastic to see the COVID Symptom Study being used as a critical tool to enable NHS England to scale research projects at pace and ultimately help find a long term solution to this virus. Unlike the contact tracing app, the COVID Symptom Study is allowing users to be actively involved in the world’s largest science research project to help fight COVID. We welcome further opportunities to collaborate with the medical and scientific community to make even more progress in the fight against this deadly disease.”
Why are we conducting this research?
Many studies have shown that COVID-19 appears to affect men more than women. Here you can see data from our app showing that men report more need for respiratory support (RS), from oxygen to ventilation after visiting hospital. This is true in the confirmed test positive group (T-COVID), as well as people who self-reported they had COVID (SR-COVID) but were not tested, and people we think had COVID based on symptoms they tracked (I-COVID).
We have also seen that in women the increased risk with age starts to become appreciable earlier than in men - this change appears to happen in the late 50s. We are currently taking a closer look to see whether this is related to the menopause.